Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurons | 22 | 2023 | 1263 | 1.620 |
Why?
|
| Hippocampus | 7 | 2012 | 594 | 1.000 |
Why?
|
| Essential Tremor | 1 | 2023 | 3 | 0.830 |
Why?
|
| Tremor | 1 | 2023 | 9 | 0.820 |
Why?
|
| Nicotine | 8 | 2017 | 302 | 0.690 |
Why?
|
| Alzheimer Disease | 6 | 2013 | 1001 | 0.680 |
Why?
|
| Locus Coeruleus | 7 | 2011 | 17 | 0.650 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 2010 | 92 | 0.630 |
Why?
|
| Brain | 7 | 2025 | 1472 | 0.620 |
Why?
|
| Amyloid beta-Protein Precursor | 5 | 2013 | 95 | 0.580 |
Why?
|
| Depression | 5 | 2019 | 863 | 0.570 |
Why?
|
| Neuropeptides | 4 | 2007 | 64 | 0.560 |
Why?
|
| Antidepressive Agents | 4 | 2019 | 65 | 0.550 |
Why?
|
| Parkinson Disease | 5 | 2025 | 210 | 0.530 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2009 | 200 | 0.510 |
Why?
|
| Presenilin-1 | 4 | 2011 | 28 | 0.510 |
Why?
|
| Astrocytes | 2 | 2016 | 244 | 0.500 |
Why?
|
| Nicotinic Agonists | 6 | 2017 | 88 | 0.480 |
Why?
|
| Hypothalamus | 3 | 2007 | 120 | 0.470 |
Why?
|
| Aging | 3 | 2011 | 783 | 0.450 |
Why?
|
| Copper | 1 | 2016 | 134 | 0.450 |
Why?
|
| Neuroprotective Agents | 2 | 2022 | 269 | 0.430 |
Why?
|
| Animals | 36 | 2025 | 16992 | 0.410 |
Why?
|
| Disease Models, Animal | 10 | 2013 | 1596 | 0.370 |
Why?
|
| Nerve Degeneration | 4 | 2010 | 111 | 0.360 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 41 | 0.330 |
Why?
|
| Mice | 16 | 2023 | 6644 | 0.320 |
Why?
|
| Immunohistochemistry | 8 | 2011 | 934 | 0.310 |
Why?
|
| Cell Count | 13 | 2014 | 145 | 0.310 |
Why?
|
| Estradiol | 1 | 2011 | 268 | 0.290 |
Why?
|
| Mice, Transgenic | 5 | 2011 | 665 | 0.290 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2012 | 135 | 0.290 |
Why?
|
| Mesencephalon | 8 | 2010 | 49 | 0.270 |
Why?
|
| Rats | 15 | 2016 | 3735 | 0.270 |
Why?
|
| Dopamine | 7 | 2022 | 275 | 0.270 |
Why?
|
| Sleep, REM | 1 | 2007 | 11 | 0.270 |
Why?
|
| Sleep Deprivation | 1 | 2007 | 28 | 0.260 |
Why?
|
| Ethanol | 4 | 2017 | 224 | 0.240 |
Why?
|
| Central Nervous System Depressants | 3 | 2017 | 42 | 0.230 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2005 | 25 | 0.230 |
Why?
|
| Cerebral Cortex | 4 | 2010 | 306 | 0.220 |
Why?
|
| Rats, Inbred WKY | 4 | 2012 | 17 | 0.220 |
Why?
|
| Species Specificity | 4 | 2016 | 286 | 0.220 |
Why?
|
| Bipolar Disorder | 1 | 2005 | 84 | 0.210 |
Why?
|
| Neuroblastoma | 2 | 2022 | 136 | 0.210 |
Why?
|
| Harmaline | 1 | 2023 | 1 | 0.210 |
Why?
|
| Sulpiride | 1 | 2023 | 6 | 0.210 |
Why?
|
| Microglia | 1 | 2025 | 208 | 0.200 |
Why?
|
| Male | 24 | 2016 | 23409 | 0.200 |
Why?
|
| Pons | 2 | 1999 | 11 | 0.190 |
Why?
|
| Rats, Wistar | 3 | 2009 | 283 | 0.190 |
Why?
|
| Cerebellum | 3 | 2010 | 79 | 0.180 |
Why?
|
| Analysis of Variance | 5 | 2009 | 575 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 141 | 0.170 |
Why?
|
| Gyrus Cinguli | 2 | 2011 | 31 | 0.170 |
Why?
|
| Humans | 21 | 2025 | 43102 | 0.160 |
Why?
|
| Female | 19 | 2013 | 24698 | 0.160 |
Why?
|
| Acetylcholine | 2 | 1999 | 77 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2016 | 1766 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 1999 | 174 | 0.150 |
Why?
|
| Antiparkinson Agents | 1 | 2019 | 14 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 1869 | 0.150 |
Why?
|
| Nerve Growth Factors | 1 | 2019 | 34 | 0.150 |
Why?
|
| Medulla Oblongata | 2 | 2010 | 42 | 0.130 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2017 | 17 | 0.130 |
Why?
|
| Flavonols | 2 | 2022 | 19 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 69 | 0.130 |
Why?
|
| X-Rays | 1 | 2016 | 19 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 30 | 0.120 |
Why?
|
| Brain Mapping | 3 | 1993 | 137 | 0.120 |
Why?
|
| Fluorescence | 1 | 2016 | 118 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 78 | 0.120 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2000 | 15 | 0.120 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 83 | 0.110 |
Why?
|
| Substantia Nigra | 5 | 2010 | 52 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 216 | 0.110 |
Why?
|
| Afferent Pathways | 1 | 2014 | 43 | 0.110 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2013 | 6 | 0.100 |
Why?
|
| Presenilins | 1 | 2013 | 7 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 77 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 82 | 0.100 |
Why?
|
| Ovariectomy | 2 | 2011 | 127 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2009 | 153 | 0.090 |
Why?
|
| Ketamine | 1 | 2012 | 13 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2013 | 883 | 0.090 |
Why?
|
| Neurotoxins | 2 | 2008 | 57 | 0.090 |
Why?
|
| Receptors, AMPA | 1 | 2012 | 58 | 0.090 |
Why?
|
| Stereotaxic Techniques | 2 | 2009 | 20 | 0.090 |
Why?
|
| Macaca mulatta | 2 | 2010 | 139 | 0.090 |
Why?
|
| Pyridines | 2 | 2008 | 139 | 0.090 |
Why?
|
| Corpus Striatum | 2 | 1989 | 121 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 1124 | 0.090 |
Why?
|
| Disease Progression | 2 | 2011 | 667 | 0.080 |
Why?
|
| Prion Diseases | 1 | 2010 | 9 | 0.080 |
Why?
|
| Hyperkinesis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prions | 1 | 2010 | 23 | 0.080 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2009 | 22 | 0.080 |
Why?
|
| Neostriatum | 1 | 2010 | 28 | 0.080 |
Why?
|
| Hominidae | 1 | 2010 | 12 | 0.080 |
Why?
|
| Anatomy, Comparative | 1 | 2010 | 4 | 0.080 |
Why?
|
| Gorilla gorilla | 1 | 2010 | 4 | 0.080 |
Why?
|
| Hylobates | 1 | 2010 | 3 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2010 | 128 | 0.080 |
Why?
|
| Neocortex | 1 | 2010 | 27 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2010 | 20 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2010 | 58 | 0.080 |
Why?
|
| Immobility Response, Tonic | 1 | 2009 | 1 | 0.080 |
Why?
|
| Gliosis | 2 | 2010 | 25 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 92 | 0.080 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 78 | 0.080 |
Why?
|
| Swimming | 1 | 2009 | 41 | 0.080 |
Why?
|
| Cholinergic Fibers | 2 | 1999 | 12 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 81 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2016 | 2157 | 0.070 |
Why?
|
| Schizophrenia | 2 | 2000 | 93 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 384 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2008 | 11 | 0.070 |
Why?
|
| Time Factors | 2 | 2010 | 1857 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2022 | 81 | 0.070 |
Why?
|
| Catecholamines | 1 | 2007 | 45 | 0.070 |
Why?
|
| Phencyclidine Abuse | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2007 | 49 | 0.060 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.060 |
Why?
|
| Schizophrenic Psychology | 1 | 2006 | 16 | 0.060 |
Why?
|
| Membrane Transport Proteins | 2 | 2000 | 100 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 437 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 2676 | 0.060 |
Why?
|
| Sarcosine | 1 | 2006 | 1 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2000 | 224 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 79 | 0.060 |
Why?
|
| Middle Aged | 8 | 2008 | 12222 | 0.060 |
Why?
|
| Body Weight | 1 | 2007 | 429 | 0.060 |
Why?
|
| Cell Death | 2 | 2005 | 278 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 149 | 0.060 |
Why?
|
| Behavior, Animal | 3 | 2013 | 373 | 0.060 |
Why?
|
| Receptors, Neuropeptide | 1 | 2004 | 6 | 0.060 |
Why?
|
| Phrenic Nerve | 1 | 2004 | 18 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 46 | 0.050 |
Why?
|
| Aged | 7 | 2008 | 8214 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2006 | 172 | 0.050 |
Why?
|
| Respiration | 1 | 2004 | 56 | 0.050 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2004 | 57 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 1999 | 386 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2004 | 90 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 138 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2005 | 1285 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2004 | 114 | 0.050 |
Why?
|
| Tegmentum Mesencephali | 3 | 1999 | 4 | 0.050 |
Why?
|
| Aconitine | 1 | 2003 | 2 | 0.050 |
Why?
|
| Enkephalins | 2 | 1993 | 31 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 30 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2022 | 55 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 86 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 81 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2006 | 694 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 1177 | 0.050 |
Why?
|
| Neuroglia | 1 | 2003 | 133 | 0.050 |
Why?
|
| Cell Survival | 2 | 2017 | 945 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2009 | 1621 | 0.040 |
Why?
|
| Estrogens | 1 | 2003 | 203 | 0.040 |
Why?
|
| Vitamin D | 1 | 2023 | 196 | 0.040 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2000 | 1 | 0.040 |
Why?
|
| Mediodorsal Thalamic Nucleus | 1 | 2000 | 2 | 0.040 |
Why?
|
| Adult | 4 | 2005 | 13872 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2008 | 2853 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1070 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1999 | 36 | 0.040 |
Why?
|
| Functional Laterality | 2 | 2010 | 89 | 0.040 |
Why?
|
| Nerve Net | 1 | 2000 | 101 | 0.040 |
Why?
|
| Mecamylamine | 2 | 2013 | 21 | 0.040 |
Why?
|
| Nicotinic Antagonists | 2 | 2013 | 36 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 1999 | 77 | 0.040 |
Why?
|
| Dizocilpine Maleate | 2 | 2008 | 43 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2017 | 29 | 0.030 |
Why?
|
| Acoustic Stimulation | 2 | 2008 | 78 | 0.030 |
Why?
|
| Apoptosis | 1 | 2005 | 1568 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2017 | 104 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 737 | 0.030 |
Why?
|
| Sclera | 1 | 2016 | 6 | 0.030 |
Why?
|
| Trabecular Meshwork | 1 | 2016 | 10 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2016 | 30 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 2016 | 18 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 64 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 169 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2016 | 132 | 0.030 |
Why?
|
| Arousal | 2 | 2006 | 95 | 0.030 |
Why?
|
| Melanins | 1 | 1995 | 42 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 147 | 0.030 |
Why?
|
| Receptors, Nicotinic | 2 | 2008 | 114 | 0.030 |
Why?
|
| Mental Disorders | 1 | 1999 | 392 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 83 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 491 | 0.030 |
Why?
|
| Pregnancy | 3 | 2005 | 1772 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 327 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 83 | 0.020 |
Why?
|
| Benzeneacetamides | 1 | 1993 | 6 | 0.020 |
Why?
|
| Receptors, Opioid, delta | 1 | 1993 | 23 | 0.020 |
Why?
|
| Receptors, Opioid, kappa | 1 | 1993 | 23 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 1993 | 31 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1992 | 32 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 1993 | 52 | 0.020 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1992 | 12 | 0.020 |
Why?
|
| MPTP Poisoning | 1 | 1992 | 12 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 138 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1994 | 321 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 704 | 0.020 |
Why?
|
| Memory | 1 | 2013 | 174 | 0.020 |
Why?
|
| Infant | 1 | 1995 | 1175 | 0.020 |
Why?
|
| Growth and Development | 1 | 2011 | 9 | 0.020 |
Why?
|
| Primates | 1 | 2011 | 39 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1995 | 1546 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2010 | 48 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2010 | 39 | 0.020 |
Why?
|
| Choline | 1 | 2010 | 61 | 0.020 |
Why?
|
| Serotonin | 1 | 2010 | 123 | 0.020 |
Why?
|
| Kaempferols | 1 | 2009 | 4 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1994 | 1271 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 52 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 1989 | 42 | 0.020 |
Why?
|
| Quercetin | 1 | 2009 | 46 | 0.020 |
Why?
|
| Homeostasis | 1 | 2010 | 192 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 146 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2008 | 18 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2008 | 14 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 173 | 0.020 |
Why?
|
| Isotopes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 10 | 0.020 |
Why?
|
| Bungarotoxins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2008 | 8 | 0.020 |
Why?
|
| Scopolamine | 1 | 2008 | 5 | 0.020 |
Why?
|
| Muscarinic Antagonists | 1 | 2008 | 11 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 712 | 0.020 |
Why?
|
| Child | 1 | 1995 | 3443 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 36 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 986 | 0.020 |
Why?
|
| Electroshock | 1 | 2006 | 15 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2009 | 561 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2006 | 150 | 0.010 |
Why?
|
| Cognition | 1 | 2009 | 473 | 0.010 |
Why?
|
| Seizures | 1 | 2006 | 79 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 352 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2004 | 21 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 2004 | 21 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1082 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 148 | 0.010 |
Why?
|
| Simian immunodeficiency virus | 1 | 2004 | 60 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 227 | 0.010 |
Why?
|
| Adolescent | 1 | 1995 | 6081 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 93 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 159 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1154 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 2003 | 1 | 0.010 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2003 | 4 | 0.010 |
Why?
|
| Densitometry | 2 | 1993 | 16 | 0.010 |
Why?
|
| Autoradiography | 2 | 1993 | 37 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 1028 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 96 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 75 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 64 | 0.010 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2000 | 3 | 0.010 |
Why?
|
| 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- | 1 | 2000 | 1 | 0.010 |
Why?
|
| Vesicular Biogenic Amine Transport Proteins | 1 | 2000 | 1 | 0.010 |
Why?
|
| Tetrabenazine | 1 | 2000 | 2 | 0.010 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2000 | 11 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2000 | 97 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 195 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1999 | 56 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1999 | 141 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 144 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1994 | 8 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 138 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1994 | 59 | 0.010 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 1993 | 6 | 0.010 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1993 | 13 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 114 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1992 | 65 | 0.010 |
Why?
|
| Gene Expression | 1 | 1994 | 701 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 1992 | 112 | 0.010 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1989 | 8 | 0.000 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1989 | 8 | 0.000 |
Why?
|
| Horseradish Peroxidase | 1 | 1989 | 27 | 0.000 |
Why?
|